Peptide directoryReproductive

Kisspeptin-10

The ten-residue core of kisspeptin, the form most used in experiments.

Where it comes from

Made in
The shared tail of the longer kisspeptins; unlike the 54, 14 and 13 it has not been isolated from tissue, and the peptide used in people is synthetic
Sent out by
With kisspeptin-54
Acts on
  • GnRH neurons
  • Pituitary gonadotrophs, weakly

What it does

  • Releases GnRH and so LH within minutes of an infusion starting
  • The smallest fully active piece: the amidated RF-amide end is what the receptor reads 1
  • Cleared in minutes, so it is infused rather than given as a single shot

In medicine

  • Infused in research to probe the reproductive axis in delayed puberty, hypothalamic amenorrhoea and in men with type 2 diabetes and low testosterone
  • In 16 children with delayed puberty, every child whose LH rose by 0.8 mIU/ml or more went through puberty, and every flat responder reached 18 without it 2

Beyond the body’s own use

  • Put side by side with kisspeptin-54 and GnRH in healthy men, the two kisspeptins did much the same and GnRH was the stronger stimulus, so the short form is used where convenience matters 3
  • Longer-acting analogues were built from its active end. Steady exposure shuts the axis down instead of switching it on: TAK-448 drove testosterone into the castration range in healthy men and in men with prostate cancer 4
  • MVT-602, from the same work, is still being tested as an ovulation trigger. Neither analogue is approved, and kisspeptin-10 itself is a research tool

Sources

  1. Kotani et al., KiSS-1 encodes kisspeptins, the natural ligands of GPR54, Journal of Biological Chemistry 2001
  2. Chan et al., Using kisspeptin to predict pubertal outcomes for youth with pubertal delay, Journal of Clinical Endocrinology and Metabolism 2020
  3. Jayasena et al., Direct comparison of intravenous kisspeptin-10, kisspeptin-54 and GnRH in healthy men, Human Reproduction 2015
  4. MacLean et al., Sustained exposure to the kisspeptin analog TAK-448 in men, Journal of Clinical Endocrinology and Metabolism 2014

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.